Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,599.00    48.00 (1.05%)
Bid:
4,593.00
Ask:
4,594.00
Spread: 1.00 (0.022%)
Market Cap: £99.03b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Directorate Change

26 Sep 2022 07:00

RNS Number : 5472A
Unilever PLC
26 September 2022
ย 

ย 

ย 

26 September 2022

ย 

Unilever CEO announces intention to retire at end of next year

Unilever today announced that CEO Alan Jope has informed the Board of his intention to retire from the company at the end of 2023, after five years in the role. The Board will now proceed with a formal search for a successor and will consider both internal and external candidates.

Unilever Chairman Nils Andersen said: "Unilever has seen improved performance, enabled by its clear strategic choices and a significant company transformation. The Board will now conduct an orderly succession process and support Alan and the management team in further driving the performance of Unilever.

"Alan's retirement next year will mark the end of a remarkable career with Unilever. Under his leadership, Unilever has made critical changes to its strategy, structure and organisation that position it strongly for success. This work continues, and we will thank Alan wholeheartedly for his leadership and contribution to our business when he leaves next year."

Unilever CEO Alan Jope said: "As I approach my fifth year as CEO, and after more than 35 years in Unilever, I believe now is the right time for the Board to begin the formal search for my successor. Growth remains our top priority, and in the quarters ahead I will remain fully focused on disciplined execution of our strategy, and leveraging the full benefits of our new organisation."

ENDS

ย 

Enquiries Media:

Jonathan Sibun +44 7779 999 683 / JSibun@tulchangroup.com

Lucila Zambrano +44 7825 273 767 / lucila.zambrano@unilever.com

ย 

Investors:

Investor Relations Teamย  investor.relations@unilever.com

ย 

Remuneration Disclosure

Alan Jope will be treated in accordance with Unilever's approved remuneration policy. He is expected to step down from the Board of Unilever and retire from employment on 31 December 2023. He will continue to be paid in line with Unilever's normal remuneration policy during this period. Treatment of all elements of his remuneration will be in line with the remuneration policy set out in the 2021 Annual Report and Accounts.

Any bonus awarded for 2022 and 2023, and any outstanding share plan awards, will be determined in line with Unilever's remuneration policy.

All payments are subject to required tax withholdings. Full details of all payments made to and receivable by Alan Jope will be disclosed on the Unilever website in due course in compliance with Section 430 (2B) of the Companies Act 2006 and in the Directors' Remuneration Report within the Company's Annual Report and Accounts for the year ending 31 December 2022, and subsequent years, as appropriate.

ย 

About Unilever ย 

Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Nutrition and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 148,000 employees and generated sales of โ‚ฌ52.4 billion in 2021.

Our vision is to be the global leader in sustainable business and to demonstrate how our purpose-led, future-fit business model drives superior performance. We have a long tradition of being a progressive, responsible business.ย ย 

The Unilever Compass, our sustainable business strategy, is set out to help us deliver superior performance and drive sustainable and responsible growth, while:ย 

- improving the health of theย planet;ย ย 

- improving people's health,ย confidenceย and wellbeing; andย ย 

- contributing to a fairer and more socially inclusive world.ย 

For more information about Unilever and our brands, please visitโ€ฏwww.unilever.com. ย 

ย 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current Covid-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2021 and the Unilever Annual Report and Accounts 2021 available on our corporate website.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
BOALAMJTMTMTTBT
Date   Source Headline
10th Feb 20236:03 pmRNSDirector/PDMR Shareholding
10th Feb 20234:49 pmRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSFinal Results
2nd Feb 20231:22 pmRNSTotal Voting Rights
30th Jan 20237:00 amRNSDirectorate Change
13th Jan 202312:06 pmRNSPDMR Shareholding
4th Jan 202312:59 pmRNSTotal Voting Rights
20th Dec 20223:07 pmRNSPDMR Shareholding
19th Dec 20225:48 pmRNSDirector/PDMR Shareholding
19th Dec 20225:45 pmRNSShare Buyback Programme
19th Dec 20225:38 pmRNSTransaction in Own Shares
16th Dec 20226:05 pmRNSTransaction in Own Shares
15th Dec 20226:07 pmRNSTransaction in Own Shares
15th Dec 20225:35 pmRNSDirector/PDMR Shareholding
15th Dec 20223:04 pmRNSBlock listing of Shares
14th Dec 20226:12 pmRNSTransaction in Own Shares
13th Dec 20226:02 pmRNSTransaction in Own Shares
13th Dec 20223:59 pmRNSDirector/PDMR Shareholding
13th Dec 20222:40 pmRNSDirector/PDMR Shareholding
12th Dec 20225:51 pmRNSTransaction in Own Shares
12th Dec 202212:47 pmRNSDirector/PDMR Shareholding
9th Dec 20225:28 pmRNSTransaction in Own Shares
8th Dec 20226:14 pmRNSTransaction in Own Shares
7th Dec 20226:05 pmRNSTransaction in Own Shares
7th Dec 20224:54 pmRNSCapital Markets Day
6th Dec 20226:01 pmRNSTransaction in Own Shares
5th Dec 20225:53 pmRNSTransaction in Own Shares
2nd Dec 20226:10 pmRNSTransaction in Own Shares
2nd Dec 20225:38 pmRNSDirector/PDMR Shareholding - Replacement
1st Dec 20225:43 pmRNSTransaction in Own Shares
1st Dec 202211:12 amRNSTotal Voting Rights
30th Nov 20225:55 pmRNSTransaction in Own Shares
29th Nov 20226:02 pmRNSTransaction in Own Shares
23rd Nov 202210:55 amRNSDirector Declaration
18th Nov 20225:33 pmRNSTransaction in Own Shares
17th Nov 20226:25 pmRNSTransaction in Own Shares
15th Nov 20226:09 pmRNSTransaction in Own Shares
14th Nov 20225:42 pmRNSTransaction in Own Shares
11th Nov 20226:03 pmRNSTransaction in Own Shares
10th Nov 20226:02 pmRNSTransaction in Own Shares
10th Nov 20222:36 pmRNSDirector/PDMR Shareholding
4th Nov 20225:57 pmRNSTransaction in Own Shares
3rd Nov 20222:58 pmRNSDirector/PDMR Shareholding
28th Oct 20225:57 pmRNSTransaction in Own Shares
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20227:00 amRNSThird Quarter 2022 Trading Statement
26th Oct 20226:01 pmRNSTransaction in Own Shares
25th Oct 20225:44 pmRNSTransaction in Own Shares
24th Oct 20226:09 pmRNSTransaction in Own Shares
21st Oct 20226:03 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.